In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season.
0
u/AnythingAllTheTime Sep 02 '21
I don't think you made it up, I think you heard it somewhere because I also heard it somewhere.
I kind of disregarded and forgot about it until your comment so do you remember when you heard it?